Evidence map›Paper›PMID 30634961›Full record

SynthesisRespiratory research2019

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review.

Conal Hayton, Dayle Terrington, Andrew M Wilson, Nazia Chaudhuri, Colm Leonard, Stephen J Fowler

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction.Chinese medical journal pulmonary and critical care medicine · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Towards Treatable Traits for Pulmonary Fibrosis.Journal of personalized medicine · 2022
    Review
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Conal HaytonDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. conalhayton@doctors.org.uk.ORCID http://orcid.org/0000-0001-8907-0643
Dayle TerringtonNorwich Medical School, University of East Anglia, Norwich, UK.
Andrew M WilsonNorwich Medical School, University of East Anglia, Norwich, UK.
Nazia ChaudhuriNorth West Lung Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Colm LeonardNorth West Lung Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Stephen J FowlerDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Manchester University NHS Foundation Trust · GBUniversity of East Anglia · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExhaled biomarkers may be related to disease processes in idiopathic pulmonary fibrosis (IPF) however their clinical role remains unclear. We performed a systematic review to investigate whether breath biomarkers discriminate between patients with IPF and healthy controls. We also assessed correlation with lung function, ability to distinguish diagnostic subgroups and change in response to treatment.

methodsMEDLINE, EMBASE and Web of Science databases were searched. Study selection was limited to adults with a diagnosis of IPF as per international guidelines.

resultsOf 1014 studies screened, fourteen fulfilled selection criteria and included 257 IPF patients. Twenty individual biomarkers discriminated between IPF and controls and four showed correlation with lung function. Meta-analysis of three studies indicated mean (± SD) alveolar nitric oxide (C

conclusionsEvidence suggests C

Indexed as

BiomarkersBreath TestsHumansIdiopathic Pulmonary FibrosisInflammation MediatorsNitric OxideOxidative StressRespiratory MechanicsBiomarkersInflammation MediatorsNitric OxideBreath testsExhaled breath condensateIdiopathic pulmonary fibrosisNitric oxideVolatile organic compounds

Identifiers

PMID30634961
PMCPMC6329167
OpenAlexW2939269880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.